Oral drug administration is the most common and widely accepted route for delivering medications. It involves taking drugs by mouth in various forms such as tablets, capsules, liquids, or suspensions. This route is preferred for its convenience, cost-effectiveness, and high patient compliance.
Forms of Oral Medications
- Tablets: Compressed powder forms of drugs
- Capsules: Medications enclosed in gelatin shells
- Liquids: Solutions or suspensions
- Sublingual: Tablets or sprays that dissolve under the tongue
- Buccal: Medications absorbed through the cheek mucosa
Advantages
- Convenient and easy to use
- Generally safe and well-tolerated
- Cost-effective
- Self-administration possible
- Wide variety of formulation options
- Stable drug forms
- High patient acceptance
Disadvantages
- First-pass metabolism through liver
- Variable absorption rates
- Food interactions possible
- Slower onset than injectable routes
- Not suitable during nausea/vomiting
- Some drugs poorly absorbed
- Taste considerations
Best Practices
- Follow specific timing instructions
- Consider food requirements
- Ensure proper storage conditions
- Take with adequate water
- Don’t crush modified-release formulations
- Check for drug interactions
- Monitor for side effects
Special Considerations
- Patient ability to swallow
- Gastrointestinal conditions
- Age-related factors
- Concurrent medications
- Timing of meals
- Need for steady drug levels
Bioavailability and Formulation Factors
Oral bioavailability depends on drug solubility, permeability, and first-pass metabolism. The Biopharmaceutics Classification System (BCS) classifies drugs into four categories: Class I (high solubility, high permeability, e.g., metoprolol), Class II (low solubility, high permeability, e.g., atorvastatin), Class III (high solubility, low permeability, e.g., cimetidine), and Class IV (low solubility, low permeability, e.g., furosemide). Formulation strategies such as salt formation (e.g., atorvastatin calcium), particle size reduction, solid dispersion, and lipid-based delivery systems can improve bioavailability of BCS Class II and IV drugs. First-pass metabolism significantly reduces the systemic availability of many drugs. For example, propranolol undergoes extensive hepatic first-pass metabolism with <25% bioavailability; verapamil has only 10–20% bioavailability due to gut wall and hepatic metabolism. Grapefruit juice inhibits intestinal CYP3A4, increasing the bioavailability of drugs like simvastatin and felodipine — patients are advised to avoid grapefruit juice while taking these medications. Food effects on absorption vary: high-fat meals increase the absorption of lipophilic drugs (e.g., griseofulvin) but delay absorption of others (e.g., alendronate). Enteric-coated and extended-release formulations protect acid-labile drugs (e.g., omeprazole) and maintain steady plasma levels, but must not be crushed or chewed.
Conclusion
Oral administration remains the preferred route for many medications due to its convenience and acceptability. Success depends on proper selection of formulation, patient education, and adherence to administration guidelines.
